FERDOTAX

Main information

  • Trade name:
  • FERDOTAX VIAL INJ
  • Dosage:
  • 20MG
  • Pharmaceutical form:
  • INJ
  • Composition:
  • VIAL
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FERDOTAX VIAL INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

20-2-2018

DOCETAXEL Injection, Solution [Baxter Healthcare Corporation]

DOCETAXEL Injection, Solution [Baxter Healthcare Corporation]

Updated Date: Feb 20, 2018 EST

US - DailyMed

22-1-2018

DOCETAXEL Injection [Amneal Biosciences LLC]

DOCETAXEL Injection [Amneal Biosciences LLC]

Updated Date: Jan 22, 2018 EST

US - DailyMed

27-11-2017

Docetaxel

Docetaxel

Docetaxel (Active substance: Docetaxel) - Centralised - Art 28 - (PSUR - Commission Decision (2017)7984 of Mon, 27 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/1152/201611

Europe -DG Health and Food Safety

27-11-2017

DOCETAXEL Injection, Solution, Concentrate [X-GEN Pharmaceuticals, Inc.]

DOCETAXEL Injection, Solution, Concentrate [X-GEN Pharmaceuticals, Inc.]

Updated Date: Nov 27, 2017 EST

US - DailyMed

11-10-2017

DOCETAXEL Injection, Solution [Hospira, Inc.]

DOCETAXEL Injection, Solution [Hospira, Inc.]

Updated Date: Oct 11, 2017 EST

US - DailyMed

3-10-2017

DOCETAXEL (Docetaxel Anhydrous) Injection, Solution [Sagent Pharmaceuticals]

DOCETAXEL (Docetaxel Anhydrous) Injection, Solution [Sagent Pharmaceuticals]

Updated Date: Oct 3, 2017 EST

US - DailyMed

7-9-2017

DOCETAXEL (Docetaxel Anhydrous) Injection, Solution [Ingenus Pharmaceuticals, LLC]

DOCETAXEL (Docetaxel Anhydrous) Injection, Solution [Ingenus Pharmaceuticals, LLC]

Updated Date: Sep 7, 2017 EST

US - DailyMed

30-8-2017

DOCETAXEL Injection, Solution [Dr. Reddy'S Laboratories Inc.]

DOCETAXEL Injection, Solution [Dr. Reddy'S Laboratories Inc.]

Updated Date: Aug 30, 2017 EST

US - DailyMed

9-6-2017

News and press releases:  Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 June 2017

News and press releases: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 June 2017

PRAC starts new referral; agrees date of its first public hearing; concludes review of docetaxel

Europe - EMA - European Medicines Agency

9-6-2017

News and press releases:  PRAC concludes there is no evidence of a change in known risk of neutropenic enterocolitis with docetaxel

News and press releases: PRAC concludes there is no evidence of a change in known risk of neutropenic enterocolitis with docetaxel

Doctors advised to follow recommendations in current product information

Europe - EMA - European Medicines Agency

23-5-2017

Taxotere (Aventis Pharma S.A.)

Taxotere (Aventis Pharma S.A.)

Taxotere (Active substance: Docetaxel) - Centralised - Yearly update - Commission Decision (2017)3539 of Tue, 23 May 2017

Europe -DG Health and Food Safety

26-4-2017

Docetaxel Winthrop (Aventis Pharma S.A.)

Docetaxel Winthrop (Aventis Pharma S.A.)

Docetaxel Winthrop (Active substance: Docetaxel) - Centralised - Yearly update - Commission Decision (2017)2857 of Wed, 26 Apr 2017

Europe -DG Health and Food Safety